Encephalitis

News Encephalitis

• New protein regulates water in the brain to control inflammation

  New research in the FASEB Journal suggests that aquaporin-4, a water transporting protein, plays a role in brain inflammation via a mechanism involving astrocyte swelling and cytokine releaseA new protein, called aquaporin-4, is making waves and found to play a key role in brain inflammation, or enc more

• to-BBB announces brain drug delivery pilot study with Janssen Pharmaceutica NV for CNS diseases

  to-BBB is entering into a pilot study with Janssen Pharmaceutica NV (Janssen) to enhance delivery of drugs to the brain for Central Nervous System (CNS) diseases. “We are very proud to join forces with Janssen” says Pieter Gaillard, CSO of to-BBB. “to-BBB’s brain delivery technology combined with more

• Virus-like particle vaccine protects monkeys from chikungunya virus

  An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Healt more

Publications Encephalitis

• Neuropsychological course of voltage‐gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis

  Background and purpose Autoantibodies (abs) to glutamic acid decarboxylase (GAD) and to voltage‐gated potassium channels (VGKC) induce distinct courses of limbic encephalitis, related to MRI findings, seizure outcome and cognition. Methods A detailed analysis of the cognitive course of th more

• Structure of human enterovirus 71 in complex with a capsid-binding inhibitor [Biochemistry]

  Human enterovirus 71 is a picornavirus causing hand, foot, and mouth disease that may progress to fatal encephalitis in infants and small children. As of now, no cure is available for enterovirus 71 infections. Small molecule inhibitors binding into a hydrophobic pocket within capsid viral protein 1 more

• Viruses, Vol. 5, Pages 834-857: Antiviral Type I and Type III Interferon Responses in the Central Nervous System

  The central nervous system (CNS) harbors highly differentiated cells, such as neurons that are essential to coordinate the functions of complex organisms. This organ is partly protected by the blood-brain barrier (BBB) from toxic substances and pathogens carried in the bloodstream. Yet, neurotropic more

Market studies Encephalitis

• Encephalitis Global Clinical Trials Review, H2, 2012

  Introduction GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H2, 2012" provides data on the Encephalitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Encephalitis. It includes an overview of the tri more

• Equine Encephalitis – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Equine Encephalitis - Pipeline Review, H2 2012', provides an overview of the Equine Encephalitis therapeutic pipeline. This report provides information on the therapeutic development for Equine Encephalitis, complete with latest updates, and special features more

• Equine Encephalitis – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Equine Encephalitis - Pipeline Review, H1 2012', provides an overview of the Equine Encephalitis therapeutic pipeline. This report provides information on the therapeutic development for Equine Encephalitis, complete with latest updates, and special features o more

Websites Encephalitis